Ding Lina, Wang Zhi-Zheng, Sun Xu-Dong, Yang Jing, Ma Chao-Ya, Li Wen, Liu Hong-Min
Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, PR China.
Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation, School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, PR China.
Bioorg Med Chem Lett. 2017 Aug 1;27(15):3521-3528. doi: 10.1016/j.bmcl.2017.05.065. Epub 2017 May 24.
Recently, Histone Lysine Specific Demethylase 1 (LSD1) was regarded as a promising anticancer target for the novel drug discovery. And several small molecules as LSD1 inhibitors in different structures have been reported. In this work, we carried out a molecular modeling study on the 6-aryl-5-cyano-pyrimidine fragment LSD1 inhibitors using three-dimensional quantitative structure-activity relationship (3D-QSAR), molecular docking and molecular dynamics simulations. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were used to generate 3D-QSAR models. The results show that the best CoMFA model has q=0.802, r=0.979, and the best CoMSIA model has q=0.799, r=0.982. The electrostatic, hydrophobic and H-bond donor fields play important roles in the models. Molecular docking studies predict the binding mode and the interactions between the ligand and the receptor protein. Molecular dynamics simulations results reveal that the complex of the ligand and the receptor protein are stable at 300K. All the results can provide us more useful information for our further drug design.
最近,组蛋白赖氨酸特异性去甲基化酶1(LSD1)被视为新型药物研发中一个有前景的抗癌靶点。并且已经报道了几种具有不同结构的作为LSD1抑制剂的小分子。在这项工作中,我们使用三维定量构效关系(3D-QSAR)、分子对接和分子动力学模拟,对6-芳基-5-氰基嘧啶片段LSD1抑制剂进行了分子建模研究。采用比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)来生成3D-QSAR模型。结果表明,最佳的CoMFA模型q = 0.802,r = 0.979,最佳的CoMSIA模型q = 0.799,r = 0.982。静电、疏水和氢键供体场在模型中起着重要作用。分子对接研究预测了配体与受体蛋白之间的结合模式和相互作用。分子动力学模拟结果表明,配体与受体蛋白的复合物在300K时是稳定的。所有这些结果可为我们进一步的药物设计提供更多有用信息。